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18-year-old man with cardiomyopathy resulting from isolated 
left ventricular non-compaction and atrial fibrillation  
diagnosed for the first time — difficult choices  
and therapeutic decisions
18-letni mężczyzna z kardiomiopatią z niescalenia mięśnia lewej komory  
oraz rozpoznanym po raz pierwszy migotaniem przedsionków  
— trudne wybory i decyzje terapeutyczne
Andrzej Jakub Sałacki, Andrzej Wysokiński
Chair and Department of Cardiology, Medical University of Lublin
Abstract
The article presents the case of an 18-year-old man who underwent ablation with the use of alternating electric cur-
rent with radio frequency of the accessory pathway due to the Wolff-Parkinson-White syndrome, was diagnosed with 
cardiomyopathy resulting from left ventricular non-compaction and was admitted to the Cardiac Intensive Care Unit as 
a result of his first bout of atrial fibrillation. After the first pharmacological cardioversion proved to be ineffective, elec-
trical cardioversion was implemented, successfully restoring sinus heart rhythm. Further difficult decisions regarding 
the patient’s drug therapy will have to be made, especially in the area of oral anticoagulants. After the analysis of the 
clinical picture, laboratory tests and echocardiography, the decision was made not to introduce oral anticoagulants 
and continue administration of the acetylsalicylic acid. There are no clear criteria and guidelines regarding the use of 
oral anticoagulant therapy in the case of cardiomyopathy resulting from left ventricular non-compaction and there are 
various views on the need of implementing such therapy after the first episode of arrhythmia and on how long it should 
last, therefore this case needs to be analyzed and discussed.
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Introduction
Left ventricular non-compaction (LVNC) is a form of fa-
milial cardiomyopathy resulting from disrupted fusion of 
myocardium trabeculae carneae during intrauterine deve-
lopment [1]. The number of diagnosed instances of LVNC 
has increased significantly within the last twenty years [2]. 
According to the European Society of Cardiology, it belongs 
to the group of unclassified cardiomyopathies [3], whereas, 
according to the American Heart Association, it is a distinct 
genetic primary cardiomyopathy [4]. A characteristic trait 
of LVNC is the presence of non-compacted, in other words 
excessively trabeculate, left ventricular (LV) myocardium. 
Layers of non-compacted and compacted LV muscle jointly 
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form a characteristic two-layer structure of myocardium 
[5]. Clinical signs depend on how disrupted the structure 
is therefore the description included both asymptomatic 
patients and symptomatic patients with disorders of LV 
systolic and diastolic functions, various forms of Cardiac 
arrhythmias or instances of embolism [6]. However, the-
re have been no therapies specifically targeted at LVNC 
yet and the treatment should incorporate the standards 
applied in the case of Cardiovascular System disorders, 
arrhythmias, as well as eliminating the risk of sudden death 
or embolic complications.
Case report
An 18-year-old man was transferred from an emergency 
department to the Cardiac Intensive Care Unit (CICU) as 
a result of his first bout of atrial fibrillation (AF) lasting from 
morning (Fig. 1). The patient in 2016 underwent ablation 
with the use of alternating electric current with radio fre-
quency of the accessory pathway (inferior septal pathway) 
due to the WPW syndrome diagnosed in 2013. Moreover, 
he was diagnosed with cardiomyopathy resulting from LVNC.
Physical examination showed abnormal heart action 
75–100/min, peripheral pulse deficit, dull and quiet heart 
sounds. The patient experienced strong heart palpitation. 
Following the recommendations after ablation, for three 
month he would take a 150 gm dose of aspirin on a regular 
basis. Laboratory tests showed the TSH of 0,285 mIU/L, 
standard (0.55–4.78) in the case of regular peripheral 
thyroid hormone levels — FT3 and FT4.
The TTE showed that LVEDd was 62 mm. Moreover, 
the patient had irregular LV muscularis increased LV tra-
beculation below papillary muscles, segmentally thinned 
LV wall in the apex area — a probable LV non-compaction 
center, heterogeneous echogenicity of interventricular 
septum and its thickened upper part (13 mm), EF ~55%, 
SF ~30%, 15 mm scope of mitral annular plane systolic 
excursion, LA ~35 mm.
Prior to his treatment, unfractionated heparin was ad-
ministered in the dose of 5 thousand units by intravenous 
bolus. The authors have considerable experience of using 
antazoline in the case of paroxysmal atrial fibrillation, thus 
the therapy began with its intravenous administration in the 
dose of 100 mg. As it turned out to be ineffective, it was 
administered with potassium, magnesium and Xylocaine 
added to the multi-electrolyte fluid. The therapy has not 
produced any results therefore slow intravenous infusion 
of 150 mg of Amiodarone in 250 ml of 5% glucose was 
initiated. Unfortunately, it has not produced any thera-
peutic effects either. As a result, a decision was made to 
perform anterolateral electrical cardioversion with 150 J 
two-phase current under total intravenous anesthesia. The 
cardioversion produced the expected results by restoring 
sinus heart rhythm. Initiation of oral anticoagulant (OAC) 
therapy introduced after electrical cardioversion proved to 
be another problematic issue, especially at duty in CICU. 
Finally, the decision was made to continue using the ASA 
preparation.
Discussion
There is a need for an in-depth discussion due to the lack 
of clear recommendations and guidelines for introducing 
and using OAC in the case of patients diagnosed with LVNC 
and patients who due to their basic disease, such as LVNC, 
also come down with malignant arrhythmias like AF which 
Figure 1. ECG taken upon admission
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sooner or later also require such therapy. In the reported 
case the TTE did not show any mitral valve defects. Based 
on the CHA2DS2VASc score, the risk of a stroke and thrombo-
embolic complications was estimated at 0 points. Following 
the ESC guideline [7] for the year 2012 regarding actions 
to be taken in the case of AF, a 4-week OAC therapy should 
be introduced after electrical cardioversion if AF lasts under 
48 hours; in the reported case it lasted for several hours.
Previous scientific reports advised to introduce anti-
coagulants in the case of this form of cardiomyopathy in 
treatment of all symptomatic patients. It was considered 
to be particularly important due to a 25-times bigger 
thromboembolic risk in the group of patients with LVNC [8]. 
Currently, a less restrictive view is prevailing – it supports 
the idea that OAC should be considered in the case of pa-
tients who have undergone embolic events and patients 
with other coexisting indications like AF, thrombus in LV or 
significant LV systolic dysfunction. OAC should not be used 
on a regular basis in the case of asymptomatic patients 
with LVNC [9]. Pignatelli et al. [10] have not observed any 
embolic complications in retrospective analysis of LVNC 
pediatric population where all patients were administered 
aspirin. The issue of applying OAC in the case of LVNC is 
still very controversial and has not been settled yet.
Conflict of interest
None declared.
Streszczenie
Przedstawiono przypadek 18 letniego mężczyzny po ablacji prądem zmiennym o częstotliwości radiowej drogi dodatko-
wego przewodzenia, z powodu zespołu WPW, z rozpoznaną kardiomiopatią z niescalenia mięśnia lewej komory, który 
w warunkach dyżuru OIOK został przyjęty z powodu rozpoznanego po raz pierwszy w życiu napadu migotania przedsion-
ków. Po nieskutecznej próbie kardiowersji farmakologicznej, konwersję do rytmu zatokowego uzyskano elektrycznie. Jak 
się okazało trudne decyzje co do dalszej farmakoterapii pacjenta, szczególnie w zakresie doustnego leczenia przeciwza-
krzepowego dopiero się zaczęły. Po analizie całokształtu obrazu klinicznego, wykonanego badania echokardiograficzne-
go oraz badań laboratoryjnych nie zdecydowano się na włączenie doustnej terapii przeciwkrzepliwej, utrzymując przyj-
mowany kwas acetylosalicylowy. Wobec braku jasnych kryteriów i zaleceń dotyczących stosowania doustnego leczenia 
przeciwzakrzepowego w kardiomiopatii z niescalenia mięśnia lewej komory, różnorodności poglądów co do potrzeby jego 
włączania po pierwszym epizodzie arytmii oraz czasu jego trwania opisany przypadek zasługuje na analizę i dyskusje.
Słowa kluczowe: zespół preekscytacji, kardiomiopatia z niescalenia mięśnia lewej komory, doustne leczenie  
przeciwzakrzepowe
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